Archives of Clinical Infectious Diseases

Published by: Kowsar

Infectious Diseases and Preventive Measures During Hajj Mass Gatherings: A Review of the Literature

Seyed Mansour Razavi 1 , Masoud Mardani 2 and Payman Salamati 3 , *
Authors Information
1 Department of Community Medicine, Tehran University of Medical Sciences, Tehran, Iran
2 Infectious Diseases Department, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Archives of Clinical Infectious Diseases: June 2018, 13 (3); e62526
  • Published Online: June 30, 2018
  • Article Type: Review Article
  • Received: January 1, 2017
  • Revised: October 6, 2017
  • Accepted: October 29, 2017
  • DOI: 10.5812/archcid.62526

To Cite: Razavi S M, Mardani M, Salamati P. Infectious Diseases and Preventive Measures During Hajj Mass Gatherings: A Review of the Literature, Arch Clin Infect Dis. 2018 ; 13(3):e62526. doi: 10.5812/archcid.62526.

Copyright © 2018, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Context
2. Evidence Acquisition
3. Results
4. Discussion
  • 1. Benkouiten S, Charrel R, Belhouchat K, Drali T, Nougairede A, Salez N, et al. Respiratory viruses and bacteria among pilgrims during the 2013 Hajj. Emerg Infect Dis. 2014;20(11):1821-7. doi: 10.3201/eid2011.140600. [PubMed: 25341199]. [PubMed Central: PMC4214309].
  • 2. Meysamie A, Ardakani HZ, Razavi SM, Doroodi T. Comparison of mortality and morbidity rates among Iranian pilgrims in Hajj 2004 and 2005. Saudi Med J. 2006;27(7):1049-53. [PubMed: 16830029].
  • 3. Alborzi A, Aelami MH, Ziyaeyan M, Jamalidoust M, Moeini M, Pourabbas B, et al. Viral etiology of acute respiratory infections among Iranian Hajj pilgrims, 2006. J Travel Med. 2009;16(4):239-42. doi: 10.1111/j.1708-8305.2009.00301.x. [PubMed: 19674262].
  • 4. Al-Tawfiq JA, Zumla A, Memish ZA. Travel implications of emerging coronaviruses: SARS and MERS-CoV. Travel Med Infect Dis. 2014;12(5):422-8. doi: 10.1016/j.tmaid.2014.06.007. [PubMed: 25047726].
  • 5. Balkhy HH, Memish ZA, Bafaqeer S, Almuneef MA. Influenza a common viral infection among Hajj pilgrims: time for routine surveillance and vaccination. J Travel Med. 2004;11(2):82-6. [PubMed: 15109471].
  • 6. Ashshi A, Azhar E, Johargy A, Asghar A, Momenah A, Turkestani A, et al. Demographic distribution and transmission potential of influenza A and 2009 pandemic influenza A H1N1 in pilgrims. J Infect Dev Ctries. 2014;8(9):1169-75. doi: 10.3855/jidc.4204. [PubMed: 25212081].
  • 7. Memish ZA, Charrel RN, Zaki AM, Fagbo SF. Alkhurma haemorrhagic fever--a viral haemorrhagic disease unique to the Arabian Peninsula. Int J Antimicrob Agents. 2010;36 Suppl 1:S53-7. doi: 10.1016/j.ijantimicag.2010.06.022. [PubMed: 20800999].
  • 8. Fagbo SF. The evolving transmission pattern of Rift Valley fever in the Arabian Peninsula. Ann N Y Acad Sci. 2002;969:201-4. [PubMed: 12381591].
  • 9. Al-Tawfiq JA, Memish ZA. The Hajj: updated health hazards and current recommendations for 2012. Euro Surveill. 2012;17(41):20295. [PubMed: 23078811].
  • 10. Rafiq SM, Rashid H, Haworth E, Booy R. Hazards of hepatitis at the Hajj. Travel Med Infect Dis. 2009;7(4):239-46. doi: 10.1016/j.tmaid.2008.09.008. [PubMed: 19717108].
  • 11. Karsany MS, Elshayeb AA, Saeed ES, Elaagib R, Ibrahim SA, Elsamani E, et al. Patterns of meningococcal infection in Sudan with emergence of Neisseria meningitidis serogroup W135. East Mediterr Health J. 2013;19(10):843-6. [PubMed: 24313147].
  • 12. Razavi SM, Mohazzab Torabi S, Salamati P. Treatment and prevention of acute respiratory infections among Iranian hajj pilgrims: a 5-year follow up study and review of the literature. Med J Islam Repub Iran. 2014;28:31. [PubMed: 25250272]. [PubMed Central: PMC4153519].
  • 13. Wilder-Smith A, Earnest A, Ravindran S, Paton NI. High incidence of pertussis among Hajj pilgrims. Clin Infect Dis. 2003;37(9):1270-2. doi: 10.1086/378748. [PubMed: 14557975].
  • 14. Al-Mazrou YY. Food poisoning in Saudi Arabia. Potential for prevention? Saudi Med J. 2004;25(1):11-4. [PubMed: 14758371].
  • 15. Gautret P, Benkouiten S, Sridhar S, Al-Tawfiq JA, Memish ZA. Diarrhea at the Hajj and Umrah. Travel Med Infect Dis. 2015;13(2):159-66. doi: 10.1016/j.tmaid.2015.02.005. [PubMed: 25765485].
  • 16. Memish Z. Brucellosis control in Saudi Arabia: prospects and challenges. J Chemother. 2001;13 Suppl 1:11-7. [PubMed: 11434523].
  • 17. Wilder-Smith A, Foo W, Earnest A, Paton NI. High risk of Mycobacterium tuberculosis infection during the Hajj pilgrimage. Trop Med Int Health. 2005;10(4):336-9. doi: 10.1111/j.1365-3156.2005.01395.x. [PubMed: 15807797].
  • 18. Razavy SM, Dabiran S, Ziaee Ardekani H. The incidence of influenza like illness and determination of the efficacy of flu vaccine in Iranian pilgrims during Hajj pilgrimage. Acta Medica Iranica. 2004;42(6):397-401.
  • 19. Razavi SM, Sabouri-Kashani A, Ziaee-Ardakani H, Tabatabaei A, Karbakhsh M, Sadeghipour H, et al. Trend of diseases among Iranian pilgrims during five consecutive years based on a Syndromic Surveillance System in Hajj. Med J Islam Repub Iran. 2013;27(4):179-85. [PubMed: 24926178]. [PubMed Central: PMC4011407].
  • 20. Ridda I, King C, Rashid H. Pneumococcal infections at Hajj: current knowledge gaps. Infect Disord Drug Targets. 2014;14(3):177-84. [PubMed: 25313100].
  • 21. Gleason JA, McNabb SJ, Abduljadayel N, Abouzeid MS, Memish ZA. Tuberculosis trends in the Kingdom of Saudi Arabia, 2005 to 2009. Ann Epidemiol. 2012;22(4):264-9. doi: 10.1016/j.annepidem.2012.01.007. [PubMed: 22364964].
  • 22. Yezli S, Memish ZA. Tuberculosis in Saudi Arabia: prevalence and antimicrobial resistance. J Chemother. 2012;24(1):1-5. doi: 10.1179/1120009X12Z.0000000001. [PubMed: 22546717].
  • 23. Al-Orainey IO. Tuberculosis infection during Hajj pilgrimage. The risk to pilgrims and their communities. Saudi Med J. 2013;34(7):676-80. [PubMed: 23860885].
  • 24. Ceyhan M, Celik M, Demir ET, Gurbuz V, Aycan AE, Unal S. Acquisition of meningococcal serogroup W-135 carriage in Turkish Hajj pilgrims who had received the quadrivalent meningococcal polysaccharide vaccine. Clin Vaccine Immunol. 2013;20(1):66-8. doi: 10.1128/CVI.00314-12. [PubMed: 23136117]. [PubMed Central: PMC3535772].
  • 25. Wu HM, Harcourt BH, Hatcher CP, Wei SC, Novak RT, Wang X, et al. Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America. N Engl J Med. 2009;360(9):886-92. doi: 10.1056/NEJMoa0806414. [PubMed: 19246360].
  • 26. Wilder-Smith A. W135 meningococcal carriage in association with the Hajj pilgrimage 2001: the Singapore experience. Int J Antimicrob Agents. 2003;21(2):112-5. [PubMed: 12615373].
  • 27. Radwan AI, Asmar JA, Frerichs WM, Bekairi SI, Al-Mukayel AA. Incidence of brucellosis in domestic livestock in Saudi Arabia. Trop Anim Health Prod. 1983;15(3):139-43. [PubMed: 6623644].
  • 28. Kelly D, Pollard AJ. W135 in Africa: origins, problems and perspectives. Travel Med Infect Dis. 2003;1(1):19-28. doi: 10.1016/S1477-8939(03)00019-X. [PubMed: 17291877].
  • 29. Annan A, Owusu M, Marfo KS, Larbi R, Sarpong FN, Adu-Sarkodie Y, et al. High prevalence of common respiratory viruses and no evidence of Middle East respiratory syndrome coronavirus in Hajj pilgrims returning to Ghana, 2013. Trop Med Int Health. 2015;20(6):807-12. doi: 10.1111/tmi.12482. [PubMed: 25688471].
  • 30. Lu L, Liu Q, Du L, Jiang S. Middle East respiratory syndrome coronavirus (MERS-CoV): challenges in identifying its source and controlling its spread. Microbes Infect. 2013;15(8-9):625-9. doi: 10.1016/j.micinf.2013.06.003. [PubMed: 23791956].
  • 31. Husain EH, Dashti AA, Electricwala QY, Abdulsamad AM, Al-Sayegh S. Absence of Neisseria meningitidis from throat swabs of Kuwaiti pilgrims after returning from the Hajj. Med Princ Pract. 2010;19(4):321-3. doi: 10.1159/000312721. [PubMed: 20516711].
  • 32. Memish ZA, Yezli S, Almasri M, Assiri A, Turkestani A, Findlow H, et al. Meningococcal serogroup A, C, W, and Y serum bactericidal antibody profiles in Hajj pilgrims. Int J Infect Dis. 2014;28:171-5. doi: 10.1016/j.ijid.2014.09.005. [PubMed: 25307887].
  • 33. Memish Z, Al Hakeem R, Al Neel O, Danis K, Jasir A, Eibach D. Laboratory-confirmed invasive meningococcal disease: effect of the Hajj vaccination policy, Saudi Arabia, 1995 to 2011. Euro Surveill. 2013;18(37). [PubMed: 24079399].
  • 34. Memish ZA, Assiri A, Almasri M, Alhakeem RF, Turkestani A, Al Rabeeah AA, et al. Prevalence of MERS-CoV nasal carriage and compliance with the Saudi health recommendations among pilgrims attending the 2013 Hajj. J Infect Dis. 2014;210(7):1067-72. doi: 10.1093/infdis/jiu150. [PubMed: 24620019].
  • 35. Read RC, Baxter D, Chadwick DR, Faust SN, Finn A, Gordon SB, et al. Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial. Lancet. 2014;384(9960):2123-31. doi: 10.1016/S0140-6736(14)60842-4. [PubMed: 25145775].
  • 36. Dabiran S, Razavi SM, Sabouri Kashani A, Karbakhsh M, Naser-Hodjati H, Peyafarin F. Effects of flu vaccine, solely or accompanied by pneumovax-23 vaccine on clinical consequences of the respiratory diseases among Iranian pilgrims in Hajj. Health. 2014;6(1):123-7. doi: 10.4236/health.2014.61019.
  • 37. Bowron CS, Maalim SM. Saudi Arabia: Hajj Pilgrimage. Traveler's Health. Centers for Disease Control and Prevention (CDCP); 2016. Available from:
  • 38. Alborzi A, Oskoee S, Pourabbas B, Alborzi S, Astaneh B, Gooya MM, et al. Meningococcal carrier rate before and after hajj pilgrimage: effect of single dose ciprofloxacin on carriage. East Mediterr Health J. 2008;14(2):277-82. [PubMed: 18561718].
  • 39. Wang M, Barasheed O, Rashid H, Booy R, El Bashir H, Haworth E, et al. A cluster-randomised controlled trial to test the efficacy of facemasks in preventing respiratory viral infection among Hajj pilgrims. J Epidemiol Glob Health. 2015;5(2):181-9. doi: 10.1016/j.jegh.2014.08.002. [PubMed: 25922328].
  • 40. Gautret P, Benkouiten S, Gaillard C, Parola P, Brouqui P. Camel milk-associated infection risk perception and knowledge in French Hajj pilgrims. Vector Borne Zoonotic Dis. 2013;13(6):425-7. doi: 10.1089/vbz.2012.1010. [PubMed: 23725087].
  • 41. Razavi SM, Masoud A, Ziaee Ardakani H, Dabiran S. Common infection and allergy induced biomarkers status in respiratory diseases among Iranian Hajj pilgrims. Health. 2014;6(1):137-40. doi: 10.4236/health.2014.61021.
  • 42. Razavi M, Salamati P, Sadeghi-Hasanabadi M. The comparison of influenza vaccine efficacy on respiratory disease among Iranian pilgrims in the 2003 and 2004 seasons. Acta Medica Iranica. 2005;43(4):279-81.
  • 43. Razavi SM, Ziaee H, Mokhtari-Azad T, Hamkar R, Doroodi T, Mirsalehian A, et al. Surveying respiratory infections among Iranian Hajj pilgrims. Iran J Clin Infect Dis. 2007;2(2):67-70.
  • 44. Razavi SM, Salamati P. Prevention of influenza at Hajj: applications for mass gatherings. J R Soc Med. 2013;106(10):386. doi: 10.1177/0141076813504327. [PubMed: 24097962]. [PubMed Central: PMC3791098].
  • 45. Salamati P, Razavi SM. Establishment of a mass gathering department within health service systems. Trav Med Infect Dis. 2015;13(1):110-1.

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments